Core Viewpoint - The strategic cooperation between Peking University International Hospital and Baiyang Pharmaceutical aims to establish a high-level precision radiotherapy center focused on brain tumors, utilizing the ZAP-X Mars surgical robot to provide innovative treatment solutions for millions of patients [1] Group 1: Strategic Cooperation - Peking University International Hospital and Baiyang Pharmaceutical signed a strategic cooperation agreement to jointly build a precision radiotherapy center [1] - The center will leverage the ZAP-X Mars surgical robot operated by Baiyang Pharmaceutical to optimize treatment scenarios for brain tumors [1] Group 2: Market Context - Brain tumors represent a global treatment challenge, with traditional surgical methods often leading to secondary injuries such as nerve damage or cerebral edema [1] - The incidence of brain tumors has been rising, particularly brain metastases, with over 1.5 million new cases reported annually in China alone [1] Group 3: Future Aspirations - The chairman of Peking University Medical Group expressed that this cooperation marks a new beginning for both parties, aiming to innovate medical services and explore industrialization [1] - The collaboration is expected to enhance diagnostic and treatment capabilities in the field of oncology, especially for brain tumors, and to foster new partnerships in other critical areas [1]
精准放疗中心将落地北京大学国际医院